Secondary Immune Thrombocytopenia Supposedly Attributable To Covid-19 Vaccination

Omar Fueyo-Rodriguez,Benjamin Valente-Acosta,Rodolfo Jimenez-Soto, Yvette Neme-Yunes, Sergio Ignacio Inclán-Alarcón,Roxana Trejo-Gonzalez,Miguel Ángel García-Salcido

BMJ CASE REPORTS（2021）

引用 31|浏览8

暂无评分

摘要

Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech).

查看译文

关键词

COVID-19, immunological products and vaccines

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要